A study conducted by researchers in Vancouver, Canada, suggests that a daily regimen of ibuprofen may help prevent Alzheimer’s disease onset if it’s started early enough. This study was published in the Journal of Alzheimer’s Disease.
The researchers, Canadian neuroscientists Dr. Patrick McGeer and Dr. Edith McGeer of Aurin Biotech, developed a saliva test to diagnose and predict Alzheimer’s disease based on levels of amyloid beta protein 42 (Abeta 42). Levels of this peptide are two to three times higher in people who are at increased risk for Alzheimer’s.
Once Abeta 42 levels are measured and indicate a person is at higher risk for Alzheimer’s, the researchers say, he or she could take early preventive measures, like a daily dose of ibuprofen, eating a Mediterranean diet, and/or consuming antioxidants such as quercetin, which is found in coffee.